SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-013895
Filing Date
2017-11-08
Accepted
2017-11-08 17:51:26
Documents
1
Period of Report
2017-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 10592
  Complete submission text file 0001179110-17-013895.txt   12136
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Issuer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11-15 SEATON PLACE ST. HELIER Y9 JE4 0QH
Business Address 11-15 SEATON PLACE ST. HELIER Y9 JE4 0QH 44-1534 833000
HBM BioCapital II LP (Reporting) CIK: 0001721496 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38268 | Film No.: 171187713